This company listing is no longer active
Rubius Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
Rubius Therapeutics has a total shareholder equity of $15.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $23.1M and $7.9M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$14.87m |
| Equity | US$15.13m |
| Total liabilities | US$7.94m |
| Total assets | US$23.07m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 5RT's short term assets ($20.2M) exceed its short term liabilities ($7.9M).
Long Term Liabilities: 5RT has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 5RT is debt free.
Reducing Debt: 5RT has no debt compared to 5 years ago when its debt to equity ratio was 5.6%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 5RT has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 5RT has less than a year of cash runway if free cash flow continues to reduce at historical rates of 23% each year